Our findings show patients with Gleason grade 7–10 prostate cancerhave 2-fold higher ST6GAL1 levels than patients diagnosed with Gleason 6 tumours (unpaired t test, p = 0.0042) (Supplementary Fig. S1c). The gene discussed is ST6GAL1; the disease is neoplasm.